Danrong Shi
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 detection and testing 3
- Structural Biology top 5%
- Animal Science and Zoology top 5%
- Virology top 10%
- General Dentistry top 10%
-
- Liver physiology and pathology 4
-
- Respiratory viral infections research 2
- Liver Disease Diagnosis and Treatment 2
-
- Bacteriophages and microbial interactions 2
-
- Bacillus and Francisella bacterial research 2
- Journals
- Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nature Cell Biology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Danrong Shi
22 papers receiving 996 citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Infectious Diseases 631
- Structural Biology 30
- Animal Science and Zoology 86
- Virology 40
- General Dentistry 15
Countries citing papers authored by Danrong Shi
This map shows the geographic impact of Danrong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danrong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danrong Shi more than expected).
Fields of papers citing papers by Danrong Shi
This network shows the impact of papers produced by Danrong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danrong Shi. The network helps show where Danrong Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Danrong Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 35 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 25 | |
| 16 | Molecular Architecture of the SARS-CoV-2 Virusbreakdown → | 2020 | 703 |
| 17 | 2020 | 1 | |
| 18 | 2020 | 73 | |
| 19 | 2020 | 3 | |
| 20 | 2015 | 30 |
About Danrong Shi
Danrong Shi is a scholar working on General Dentistry, Infectious Diseases and Hepatology, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), Liver physiology and pathology (4 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 detection and testing (3 papers), Respiratory viral infections research (2 papers), Bacteriophages and microbial interactions (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Bacillus and Francisella bacterial research (2 papers). The work is most often cited by research in Infectious Diseases (631 citations), Structural Biology (30 citations) and Animal Science and Zoology (86 citations). Danrong Shi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hangping Yao, Lanjuan Li, Nanping Wu, Tian-Hao Weng, Zhigang Wu, Linfang Cheng, Xiangyun Lu, Sai Li, Zheyuan Zhang and Jialu Xu. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.